Astoria Portfolio Advisors LLC. decreased its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 3.9% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,758 shares of the conglomerate’s stock after selling 72 shares during the quarter. Astoria Portfolio Advisors LLC.’s holdings in Danaher were worth $357,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also recently bought and sold shares of DHR. GAMMA Investing LLC raised its stake in Danaher by 22.2% during the first quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate’s stock valued at $1,871,000 after buying an additional 1,660 shares in the last quarter. Assenagon Asset Management S.A. grew its holdings in shares of Danaher by 1.0% during the first quarter. Assenagon Asset Management S.A. now owns 20,634 shares of the conglomerate’s stock valued at $4,230,000 after purchasing an additional 203 shares during the last quarter. NorthCrest Asset Manangement LLC bought a new position in shares of Danaher during the first quarter valued at approximately $262,000. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Danaher by 4.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 207,169 shares of the conglomerate’s stock valued at $42,470,000 after purchasing an additional 7,907 shares during the last quarter. Finally, Opal Wealth Advisors LLC bought a new position in shares of Danaher during the first quarter valued at approximately $138,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities analysts have recently commented on the company. Royal Bank Of Canada set a $241.00 target price on Danaher in a report on Tuesday, September 2nd. Bank of America lowered their target price on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a report on Monday, September 22nd. Barclays reaffirmed an “overweight” rating and set a $225.00 target price (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Robert W. Baird increased their price objective on Danaher from $225.00 to $226.00 and gave the stock an “outperform” rating in a report on Friday, July 18th. Finally, Redburn Partners set a $220.00 price objective on Danaher in a report on Wednesday. Seventeen analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $244.60.
Danaher Stock Performance
DHR opened at $202.53 on Monday. The firm has a market cap of $145.02 billion, a PE ratio of 43.09, a P/E/G ratio of 2.88 and a beta of 0.77. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The business has a fifty day simple moving average of $200.66 and a 200-day simple moving average of $197.07. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.41.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company’s revenue was up 3.4% compared to the same quarter last year. During the same period last year, the company posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.
Danaher Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is currently 27.23%.
Insider Buying and Selling at Danaher
In other news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 11.10% of the stock is currently owned by corporate insiders.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- What Do S&P 500 Stocks Tell Investors About the Market?
- Could Target’s Week of Discounts Come Full Circle for Investors?
- Trading Halts Explained
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.